Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -2.40% | -19.21% | -65.16% |
May. 14 | TRACON Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.35M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -21M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.33
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.8% |
Latest transcript on TRACON Pharmaceuticals, Inc.
1 day | -2.40% | ||
1 week | -19.21% | ||
Current month | -4.69% | ||
1 month | -34.41% | ||
3 months | -67.47% | ||
6 months | -70.53% | ||
Current year | -65.16% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 1.22 | -2.40% | 77,849 |
24-06-04 | 1.25 | -1.57% | 72,346 |
24-06-03 | 1.27 | -0.78% | 101,485 |
24-05-31 | 1.28 | +2.40% | 46,453 |
24-05-30 | 1.25 | -17.22% | 271,139 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.16% | 3.35M | |
-0.28% | 90.59B | |
0.00% | 38.99B | |
-8.52% | 34.09B | |
+64.13% | 26.38B | |
-17.37% | 15.02B | |
-5.99% | 13.17B | |
-10.69% | 11.88B | |
-47.78% | 10.65B | |
+8.09% | 9.25B |
- Stock Market
- Equities
- TCON Stock